Business, Policy & Funding

Carrick Therapeutics Receives $35M Investment From Pfizer; Raises $25M in Series C Funding Round

Theralink Technologies to Raise $3.1M in Private Placements

Alaunos Therapeutics Expecting $15.7M in Common Stock Offering

Genentech to Withdraw First-Line Tecentriq Bladder Cancer Indication

AstraZeneca to Acquire Cell Therapy Firm Neogene Therapeutics

Exscientia Receives Regulatory Nod to Start AI-Aided Phase I/II Trial

NICE Recommends BMS's Opdivo Plus Chemo for HER2-Negative, PD-L1-Positive Gastric Cancer

OncoDNA, Eli Lilly Partner on Thyroid Cancer Biomarker Testing

Halo Diagnostics, Ikonopedia Partner to Provide Genetic Testing for Breast Cancer

Biocare Medical Acquires Empire Genomics

Opna Bio Launches With $38M Series A Financing

Legend Biotech to Launch CAR T-Cell Therapy Trial for Small Cell Lung Cancer, Neuroendocrine Tumors

Iovance Announces Another Regulatory Delay in Quest for First-In-Class TIL Therapy Approval

FogPharma Raises $178M in Series D Financing

In Brief This Week: Caris Life Sciences, DermTech, Sonora Quest Laboratories, CellVax, Mainz Biomed

NeoGenomics, ImmunoGen Ink Testing Deal for Newly Approved Folate Receptor Drug

Takeda to Discuss Positive Phase III Iclusig Data in Upfront ALL With Regulators

Rezo Therapeutics Launches With $78M in Series A Funding

Novigenix Raises $14M in First Closing of Series B

NICE Approves Takeda's Exkivity for EGFR Exon 20 Insertion-Positive NSCLC